• Explore /
  • Poster
  • / Final results of first European phase II trial of intravenous cetuximab (Cet) and hepatic artery infusion of irinotecan, 5-fluorouracil and oxaliplatin in patients (pts) with unresectable liver metastases from <i>wt</i> KRAS colo-rectal cancer (LM-CRC) after systemic treatment failure (OPTILIV, NCT00852228).

Final results of first European phase II trial of intravenous cetuximab (Cet) and hepatic artery infusion of irinotecan, 5-fluorouracil and oxaliplatin in patients (pts) with unresectable liver metastases from wt KRAS colo-rectal cancer (LM-CRC) after systemic treatment failure (OPTILIV, NCT00852228).

Abstract Poster

Authors

null

Francis Levi

Medical Oncology Department, INSERM U776, Paul Bro

Francis Levi , Valerie Boige , Mohamed Hebbar , Denis Smith , Céline Lepère , C. Focan , Rosine Guimbaud , Carlos Carvalho , Salvatore Tumolo V, Pasquale Innominato , Yves Ajavon , Stephanie Truant , Denis Castaing , Thierry De Baere , Francis Kunstlinger , Abdoulaye Karaboué , Mohamed Bouchahda , Philippe Rougier , Rene Adam , Michel Ducreux

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Cancers of the Colon and Rectum

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT00852228

Citation

J Clin Oncol 31, 2013 (suppl 4; abstr466)

DOI

10.1200/jco.2013.31.4_suppl.466

Abstract #

466

Poster Bd #

C22

Abstract Disclosures

Similar Posters

First Author: Francis Levi

First Author: Valerie Boige

First Author: Francis Levi

First Author: Veronica Conca